Warm autoimmune hemolytic anemia medical therapy

Revision as of 17:11, 21 September 2012 by Vishnu Vardhan Serla (talk | contribs) (Created page with "__NOTOC__ {{Warm autoimmune hemolytic anemia}} {{CMG}} ==Overview== ==Medical Therapy== Corticosteroids and immunoglobulins are two commonly used treatments for warm antib...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Warm autoimmune hemolytic anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Warm autoimmune hemolytic anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Serum Haptoglobin Level

Chest X Ray

Peripheral Smear

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Warm autoimmune hemolytic anemia medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Warm autoimmune hemolytic anemia medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Warm autoimmune hemolytic anemia medical therapy

CDC on Warm autoimmune hemolytic anemia medical therapy

Warm autoimmune hemolytic anemia medical therapy in the news

Blogs on Warm autoimmune hemolytic anemia medical therapy

Directions to Hospitals Treating Warm autoimmune hemolytic anemia

Risk calculators and risk factors for Warm autoimmune hemolytic anemia medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Medical Therapy

Corticosteroids and immunoglobulins are two commonly used treatments for warm antibody AIHA. Initial Tx consists of prednisone. If ineffective, splenectomy should be considered. If refractory to both these therapies, consider rituximab, danazol, cyclosphosphamide, azathioprine, or cyclosporine, High dose intravenous immune globulin may be effective in controlling hemolysis, but the benefit is short lived (1-4 weeks), and the therapy is very expensive.

References

Template:WH Template:WS